Cytokinetics, Incorporated · NASDAQ:CYTK
The Vanguard Group's stake in Cytokinetics, Incorporated fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 26, 2026
The Vanguard Group's stake in Cytokinetics, Incorporated fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 26, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Cytokinetics, Incorporated
- The Vanguard Group
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · The Vanguard Group · Jan 8, 2025
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026